COVID-19-related acute necrotizing encephalopathy with extremely high interleukin-6 and RANBP2 mutation in a patient with recently immunized inactivated virus vaccine and no pulmonary involvement. (P1-1.Virtual)

dc.contributor.authorThanakit Pongpitakmetha
dc.contributor.authorPasin Hemachudha
dc.contributor.authorWanakorn Rattanawong
dc.contributor.authorPoosanu Thanapornsangsuth
dc.contributor.authorThiravat Hemachudha
dc.date.accessioned2026-05-08T19:23:40Z
dc.date.issued2022-5-3
dc.description.abstractTo report the first case of COVID-19 associated acute necrotizing encephalopathy (ANE) without pulmonary disease in a patient with an extremely high interleukin-6 (IL-6) level and Ran Binding Protein 2 (RANBP2) mutation.
dc.identifier.doi10.1212/wnl.98.18_supplement.1559
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/19191
dc.publisherNeurology
dc.subjectInfectious Encephalopathies and Encephalitis
dc.subjectSARS-CoV-2 and COVID-19 Research
dc.subjectRespiratory viral infections research
dc.titleCOVID-19-related acute necrotizing encephalopathy with extremely high interleukin-6 and RANBP2 mutation in a patient with recently immunized inactivated virus vaccine and no pulmonary involvement. (P1-1.Virtual)
dc.typeArticle

Files

Collections